Correlation of anti-tumour drug resistance with epigenetic regulation

During treatment, the development of drug-resistant tumours remains an important challenge in cancer treatment. Epigenetic changes have been reported as one of the mechanisms for anti-tumour drug resistance. In clinical practice, a combination of epigenetic-related drugs can be considered as a futur...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayashi, Takuma, Konishi, Ikuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884424/
https://www.ncbi.nlm.nih.gov/pubmed/33268818
http://dx.doi.org/10.1038/s41416-020-01183-y
_version_ 1783651413657649152
author Hayashi, Takuma
Konishi, Ikuo
author_facet Hayashi, Takuma
Konishi, Ikuo
author_sort Hayashi, Takuma
collection PubMed
description During treatment, the development of drug-resistant tumours remains an important challenge in cancer treatment. Epigenetic changes have been reported as one of the mechanisms for anti-tumour drug resistance. In clinical practice, a combination of epigenetic-related drugs can be considered as a future selection of cancer therapeutic drugs.
format Online
Article
Text
id pubmed-7884424
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-78844242021-12-03 Correlation of anti-tumour drug resistance with epigenetic regulation Hayashi, Takuma Konishi, Ikuo Br J Cancer Editorial During treatment, the development of drug-resistant tumours remains an important challenge in cancer treatment. Epigenetic changes have been reported as one of the mechanisms for anti-tumour drug resistance. In clinical practice, a combination of epigenetic-related drugs can be considered as a future selection of cancer therapeutic drugs. Nature Publishing Group UK 2020-12-03 2021-02-16 /pmc/articles/PMC7884424/ /pubmed/33268818 http://dx.doi.org/10.1038/s41416-020-01183-y Text en © Cancer Research UK 2020 https://creativecommons.org/licenses/by/4.0/ Note This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).
spellingShingle Editorial
Hayashi, Takuma
Konishi, Ikuo
Correlation of anti-tumour drug resistance with epigenetic regulation
title Correlation of anti-tumour drug resistance with epigenetic regulation
title_full Correlation of anti-tumour drug resistance with epigenetic regulation
title_fullStr Correlation of anti-tumour drug resistance with epigenetic regulation
title_full_unstemmed Correlation of anti-tumour drug resistance with epigenetic regulation
title_short Correlation of anti-tumour drug resistance with epigenetic regulation
title_sort correlation of anti-tumour drug resistance with epigenetic regulation
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884424/
https://www.ncbi.nlm.nih.gov/pubmed/33268818
http://dx.doi.org/10.1038/s41416-020-01183-y
work_keys_str_mv AT hayashitakuma correlationofantitumourdrugresistancewithepigeneticregulation
AT konishiikuo correlationofantitumourdrugresistancewithepigeneticregulation

Ejemplares similares